Search results for "Random"

showing 10 items of 3931 documents

Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005

2007

Purpose To examine the recent epidemiological studies on aspirin use and breast cancer risk published from 2001 to 2005 within a meta-analysis, to investigate reasons for heterogeneity between the individual studies and to analyse a dose-response-relationship considering frequency and duration of use. Methods We systematically searched for cohort-studies and case-control-studies from 2001–2005, which evaluated the association between aspirin and breast cancer risk. We calculated a pooled estimate for the relative risk (RR) and investigated reasons for heterogeneity between the individual studies and analysed a dose-response-relationship using random effects mixed models. Results We identifi…

RiskOncologymedicine.medical_specialtyEpidemiologyBreast NeoplasmsDrug Administration ScheduleBreast cancerInternal medicineEpidemiologymedicineHumansPharmacology (medical)Meta-regressionAspirinModels StatisticalAspirinDose-Response Relationship Drugbusiness.industryAnti-Inflammatory Agents Non-SteroidalReproducibility of Resultsmedicine.diseaseRandom effects modelSurgeryMeta-analysisRelative riskRegression AnalysisFemaleObservational studyControlled Clinical Trials as Topicbusinessmedicine.drugPharmacoepidemiology and Drug Safety
researchProduct

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis

2012

Background Routine second-look endoscopy in modern-era peptic ulcer bleeding (PUB) remains controversial. Objective To assess the effectiveness of routine second-look endoscopy in patients with PUB exhibiting high-risk stigmata after standard medical care and endoscopic therapy. Design Comprehensive literature searches (1990-2011) were performed, seeking randomized trials comparing a routine with an as-needed second endoscopy. Main Outcome Measurements The main outcome was rebleeding. Secondary outcomes were surgery and mortality. Subanalyses assessed the influence of study quality, rebleeding definitions, endoscopic hemostasis modality, and proton pump inhibitor (PPI) therapies. Analyses w…

Riskmedicine.medical_specialtymedicine.drug_classMEDLINEProton-pump inhibitorlaw.inventionRandomized controlled trialRecurrencelawOdds RatiomedicineHumansRadiology Nuclear Medicine and imagingModels Statisticalmedicine.diagnostic_testbusiness.industryHemostasis EndoscopicGastroenterologyProton Pump InhibitorsOdds ratioConfidence intervalSurgeryEndoscopyPeptic Ulcer HemorrhageTreatment OutcomeMeta-analysisHemostasisbusinessGastrointestinal Endoscopy
researchProduct

Rivaroxaban in Peripheral Artery Disease after Revascularization

2020

Abstract Background Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and ...

RivaroxabanAspirinmedicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentGeneral MedicineDisease030204 cardiovascular system & hematologyRevascularizationlaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trialMulticenter studylawInternal medicineCardiologyMedicine030212 general & internal medicinebusinessmedicine.drugNew England Journal of Medicine
researchProduct

An API for Advanced Traffic Control in Diffserv Routers

2003

Distributed per-flow admission control is a promising solution for Differentiated Services networks. Its deployment in DiffSery domains requires the ability to suitably configure, in each network router, low-level packet forwarding mechanisms, such as packet dropping algorithms driven by traffic measurements. In this paper we first show that performance effectiveness is achieved by means of non traditional configuration of the forwarding mechanisms. Hence, we propose a modular Application Program Interface that allows to flexibly and adaptively configure the forwarding/dropping behavior associated to a router’s output queue, well beyond the traditional RED/RIO active queue management scheme…

RouterEngineeringDifferentiated servicesbusiness.industryNetwork packetPacket forwardingRandom early detectionAdmission controlActive queue managementbusinessQueueComputer network
researchProduct

Small-diameter titanium Grade IV and titanium-zirconium implants in edentulous mandibles: three-year results from a double-blind, randomized controll…

2015

OBJECTIVE: The aim of this study was to compare crestal bone-level changes, soft tissue parameters and implant success and survival between small-diameter implants made of titanium/zirconium (TiZr) alloy or of Grade IV titanium (Ti) in edentulous mandibles restored with removable overdentures. MATERIALS AND METHODS: This was a randomized, controlled, double-blind, split-mouth multicenter clinical trial. Patients with edentulous mandibles received two Straumann bone-level implants (diameter 3.3 mm), one of Ti Grade IV (control) and one of TiZr (test), in the interforaminal region. Implants were loaded after 6-8 weeks and removable Locator-retained overdentures were placed within 2 weeks of l…

RoxolidMaleSmall diameterSLActive surfaceDentistrychemistry.chemical_elementMandibleCONVENTIONAL COMPLETE DENTURESlaw.inventionDouble blindRETROSPECTIVE EVALUATION IMPLANTDouble-Blind MethodRandomized controlled triallawMARGINAL BONE LOSSHumansJaw EdentulousMedicineMANDIBULAR 2-IMPLANT OVERDENTURES610 Medicine & healthAgedDental ImplantsTitaniumPATIENT SATISFACTIONTitanium/zirconiumSTRESS-DISTRIBUTIONbusiness.industryDental Implantation Endosseoustechnology industry and agricultureWITHIN-SUBJECT COMPARISONSSoft tissueDIFFERENT LOADING PROTOCOLSDenture Overlayequipment and suppliesTitanium zirconiumddc:617.6Treatment OutcomeDental Prosthesis DesignchemistryImplant typesedentulousFemaleZirconiumImplantFINITE-ELEMENT-ANALYSISOral SurgerybusinessDental AlloysTitaniumClinical Oral Implants Research
researchProduct

Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlle…

2015

BACKGROUND The aim of this study was to compare the 5-year survival and success rates of 3.3 mm dental implants either made from titanium-zirconium (TiZr) alloy or from Grade IV titanium (Ti Grade IV) in mandibular implant-based removable overdentures. METHODS The core study had a follow-up period of 36 months and was designed as a randomized, controlled, double-blind, split-mouth multicenter clinical trial. Patients with edentulous mandibles received two Straumann Bone Level implants (diameter 3.3 mm, SLActive®), one of TiZr (test) and one of Ti Grade IV (control), in the interforaminal region. This follow-up study recruited patients from the core study and evaluated the plaque and sulcus …

RoxolidSmall diameterSplit-mouthDentistrychemistry.chemical_element610 Medicine & healthMandiblelaw.inventionTiZrDouble blindstomatognathic systemRandomized controlled trialDouble-Blind MethodlawOverdenturesAlloysMedicineHumansJaw Edentulous610 Medicine & healthGeneral DentistrySurvival rateOrthodonticsDental ImplantsTitaniumbusiness.industryDentistry(all)Ti Grade IVDental Implantation Endosseoustechnology industry and agricultureSLActiveequipment and suppliesDenture OverlayTitanium zirconiumddc:617.6stomatognathic diseaseschemistryDental Prosthesis DesignOral and maxillofacial surgeryImplantZirconiumbusinessTitaniumFollow-Up StudiesResearch Article
researchProduct

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

2015

Hepatocellular carcinoma is a challenging malignancy of global importance. It is the sixth most common solid malignancy and the third leading cause of cancer-related death, worldwide. Curative treatments at early stages include liver transplantation, resection and percutaneous ablation, while transarterial chemoembolization can improve survival in patients with intermediate tumor stage. Patients with mild, related symptoms and/or macrovascular invasion or extrahepatic spread are classified under the advanced stage. The standard of care in this group is sorafenib, an inhibitor of Raf kinase and vascular endothelial growth factor receptor, whose effectiveness has been proven by 2 recent rando…

SHARPOncologyHepatocellular carcinomamedicine.medical_treatmentOLTLiver transplantationGastroenterologyLiver cirrhosilaw.inventionAntineoplastic AgentRandomized controlled triallawPractice Patterns Physicians'Randomized Controlled Trials as TopicNexavarMedicine (all)Liver NeoplasmsGastroenterologyGeneral MedicineSorafenibLocoregional therapiePercutaneous ethanol injectionLiver NeoplasmRaf kinaseHepatocellular carcinomaLiver cancerLiver cancerHumanmedicine.drugSorafenibNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsMalignancyTransarterial chemoembolizationInternal medicinemedicineCarcinomaChemotherapyHumansChemoembolization Therapeuticbusiness.industryPhenylurea CompoundsRadiofrequency ablationResectionmedicine.diseaseBCLCPercutaneous ethanol injectionbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Usage and Dose Response of a Mobile Acceptance and Commitment Therapy App: Secondary Analysis of the Intervention Arm of a Randomized Controlled Trial

2016

Background: Mobile phone apps offer a promising medium to deliver psychological interventions. A mobile app based on Acceptance and Commitment Therapy (ACT) was developed and studied in a randomized controlled trial (RCT). Objective: To study usage metrics of a mobile ACT intervention and dose-response relationship between usage and improvement in psychological flexibility. Methods: An RCT was conducted to investigate the effectiveness of different lifestyle interventions for overweight people with psychological stress. This paper presents a secondary analysis of the group that received an 8-week mobile ACT intervention. Most of the analyzed 74 participants were female (n=64, 86%). Their me…

SMARTPHONE APPLICATION020205 medical informaticsretrospective studyPsychological intervention02 engineering and technologyLogistic regressionAcceptance and commitment therapy3124 Neurology and psychiatrylaw.invention0302 clinical medicinePROGRAMSRandomized controlled trialInterquartile rangelaw0202 electrical engineering electronic engineering information engineeringmobiilisovelluksetWEB-BASED ACCEPTANCEMedicine030212 general & internal medicineadherencePREDICTORSmHealthApplied Psychologyta515mobile appsT58.5-58.64DEPRESSION3. Good healthHEALTHPublic aspects of medicineRA1-1270medicine.medical_specialty515 Psychologyhyväksymis- ja omistautumisterapiaSTUDENTSHealth InformaticsContext (language use)Information technology03 medical and health sciencesNursingAcceptance and Commitment TherapyOriginal Paperbusiness.industryTillämpad psykologiSMOKING-CESSATIONConfidence interval3141 Health care scienceacceptance and commitment therapyPhysical therapyATTRITIONbusiness
researchProduct

A genomic study of the inter-ORF distances in Saccharomyces cerevisiae.

2006

The genome of eukaryotic microbes is usually quite compacted. The yeast Saccharomyces cerevisiae is one of the best-known examples. Open reading frames (ORFs) occupy about 75% of the total DNA sequence. The existence of other, non-protein coding genes and other genetic elements leaves very little space for gene promoters and terminators. We have performed an in silico study of inter-ORF distances that shows that there is a minimum distance between two adjacent ORFs that depends on the relative orientation between them. Our analyses suggest that different kinds of promoters and terminators exist with regard to their length and ability to overlap each other. The experimental testing of some p…

Saccharomyces cerevisiaeBioengineeringSaccharomyces cerevisiaeApplied Microbiology and BiotechnologyBiochemistryGenomeDNA sequencingOpen Reading FramesTranscripció genèticaGeneticsORFSLeast-Squares AnalysisGeneGeneticsbiologyReverse Transcriptase Polymerase Chain ReactionPromoterRNA Fungalbiology.organism_classificationBlotting NorthernRandom Amplified Polymorphic DNA TechniqueOpen reading frameTerminator (genetics)Genome FungalBiotechnologyYeast (Chichester, England)
researchProduct

Assessment of the capacity of a pyrophosphate-based mouth rinse to inhibit the formation of supragingival dental calculus. a randomized double-blind …

2019

Background This study aimed to analyze the efficacy of an anti-calculus mouth rinse and its possible adverse effects on the mucosa and teeth. Material and Methods This randomized double-blind placebo-controlled clinical trial included 40 patients with treated and managed periodontal disease, all with a history of rapid calculus formation. Patients used a pyrophosphate-based test mouth rinse (B) or a placebo (A). A range of parameters were measured for: saliva (saliva flow, pH and chemical composition); calculus (Volpe-Manhold [V-M] index, weight, and volume); adverse effects on mucosa and teeth; and the patients’ subjective perceptive of mouth rinse efficacy. Results The test mouth rinse B …

SalivaMouthwashesPlacebolaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind Methodstomatognathic systemRandomized controlled triallawDentifriceCalculusHumansMedicineDental CalculusAdverse effectGeneral DentistryDentifricesOral Medicine and Pathologybusiness.industryResearchCalculus (dental)030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDiphosphatesstomatognathic diseasesOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASUreaUric acidSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct